Litigation Details for UCB Inc. v. Watson Laboratories Inc. (NV) (D. Del. 2014)
✉ Email this page to a colleague
UCB Inc. v. Watson Laboratories Inc. (NV) (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-08-21 |
| Court | District Court, D. Delaware | Date Terminated | 2017-12-13 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | Sherry R. Fallon |
| Parties | UCB INC.; WATSON LABORATORIES INC. | ||
| Patents | 6,699,498; 6,884,434; 7,413,747; 8,246,979; 8,246,980; 8,617,591 | ||
| Attorneys | Heather M. Schneider; Paul Saindon | ||
| Firms | Morris, Nichols, Arsht & Tunnell; Paul Saindon | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in UCB Inc. v. Watson Laboratories Inc. (NV)
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for UCB Inc. v. Watson Laboratories Inc. (NV) (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-08-21 | 1 | Complaint | United States Patent Nos. 6,699,498 . (“the °498 Patent”); 6,884,434 (“the *434 Patent”); 7,413,747 (…“Notification of Certification for U.S. Patent Nos. 6,699,498; 6,884,434; 7,413,747; 8,246,979; 8,246,…498 Patent; the °434 Patent; the ’747 Patent; the 979 Patent; the 980 Patent; and the ’591 Patent. This… (“the ’747 Patent”); 8,246,979 (“the 979 Patent”); 8,246,980 (“the *980 Patent”); and 8,617,591 (“the…ACTION 1. This action for patent infringement, brought pursuant to the patent laws of the United States | External link to document |
| 2015-11-09 | 111 | Claim Construction Chart | APPENDIX A Agreed Upon Claim Term of U.S. Patent No. 6,884,434 Claim Term …constructions of the agreed upon and disputed terms of the Patents- in-Suit are attached hereto as Appendices A-D… APPENDIX B Agreed Upon Claim Terms of U.S. Patent No. 7,413,747 Claim Term … APPENDIX C Agreed Upon Claim Term of U.S. Patent No. 8,617,591 Claim Term … adhesive matrix” Disputed Claim Term of U.S. Patent No. 8,617,591 Claim Term | External link to document |
| 2016-01-08 | 120 | Memorandum and Order | disputed claim language of U.S. Patent No. 8,617,591 (“the '591 patent") shall be construed consistent….” (4:42-47) 2. During prosecution of the ‘591 patent, the applicant argued that claim 8 (which later… 13 December 2017 1:14-cv-01083 830 Patent None District Court, D. Delaware | External link to document |
| 2017-02-24 | 193 | Notice of Service | Potts, Ph.D. on the Invalidity of U.S. Patent Nos. 6,884,434 and 8,932,665, the Opening Expert Report…of Robin D. Rogers, Ph.D. on Invalidity of U.S. Patent No. 8,232,414 filed by Actavis Laboratories UT … 13 December 2017 1:14-cv-01083 830 Patent None District Court, D. Delaware | External link to document |
| 2017-03-24 | 202 | Notice of Service | Gokel, Ph.D. on the Non-Infringement of U.S. Patent No. 6,884,434; Rebuttal Expert Report of Russell O. Potts…Non-Infringement and Obviousness of U.S. Patent Nos. 6,884,434 and 8,932,665; and Rebuttal Expert Report… 13 December 2017 1:14-cv-01083 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
